NAYA (NAYA Biosciences) Earnings per share growth rate in current year
The annual EPS volatility reflects profit dynamics, where 92.70 indicates the current value of the metric. The financial profile of NAYA Biosciences (NAYA) is constrained by R&D expenses but protected by antibody patents. Its status as a scientific leader reinforces investor confidence in the development of multispecific proteins. The company's technologies are based on training the immune system to accurately recognize tumors, which helps combat aggressive forms of cancer.
Financial and market metric breakdowns for nayabiosciences.com (NAYA)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
- earnings and market ratios statistics:
NAYA - Company Net Income|Expected Net Profit NAYA Biosciences|NAYA - Price to Earnings Ratio|Market Cap to Projected Earnings NAYA Biosciences|NAYA - PEG Multiple|Enterprise Value to EBITDA Ratio NAYA Biosciences|NAYA - Operating profit EBITDA|Net earnings per share for the last four quarters NAYA Biosciences|NAYA - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months nayabiosciences.com|NAYA - Earnings per share growth in current year|Projected earnings per share growth rate for next year NAYA Biosciences
- sales volume and revenue information:
Summary company analysis:NAYA Bio (NAYA)
Institutional capital assesses the attractiveness of NAYA Biosciences (NAYA) through the dynamics of profit generation efficiency. This relative annual growth in net income per share measures the percentage deviation of the current EPS from the value of the same period last year, revealing hidden profitability trends. The stability of this metric confirms the asset's reliability, reflecting financial resilience in organizing complex biomaterial logistics for oncology research.
Direct competitors
Earnings per share growth rate in current year BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year revmed.com RVMD|Earnings growth in current year AAPG|Net earnings per share growth this year CG Oncology CGON|Earnings per share growth in current year UroGen URGN|Expected net earnings per share growth this year Bicara Bio (BCAX)|PSNL - Earnings per share growth in current year|ERAS - Earnings growth in current year|DCTH: Earnings growth in current year|Y-mAbs Therapeutics, Inc. (YMAB) - Earnings growth in current year|Net earnings per share growth this year AURA|Earnings per share growth rate in current year candeltx.com CADL|Earnings growth in current year ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Earnings per share increase in current year|Earnings growth in current year ACTU (Actuate Therapeutics Inc)|Earnings per share increase in current year CTOR|tuhurabio.com - Earnings growth in current year|Earnings per share increase in current year TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Earnings per share growth in current year|WHWK - Expected net earnings per share growth this year|Earnings per share growth in current year tscan.com|CSBR: Earnings per share increase in current year|Earnings per share growth in current year XBiotech USA (XBIT)|CVM: Earnings per share trend in current year|Earnings per share growth in current year ostherapies.com OSTX|Net earnings per one share growth for the current year RADX (Radiopharm Theranostics Limited)|Artiva - Earnings growth in current year|ANL: Earnings per share growth in current year|VERU: Earnings growth in current year|Earnings per share trend in current year TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Earnings growth in current year|Earnings per share growth rate in current year renovarobio.com RENB|Earnings per share growth in current year muraloncology.com (MURA)|Net earnings per one share growth for the current year KAPA|Earnings growth in current year OKUR (onkuretherapeutics.com)|Net earnings per one share growth for the current year GDTC (CytoMed)|Curis - Earnings growth in current year|APLM: Earnings per share growth in current year|Tharimmune (THAR) - Earnings per share growth in current year|Net earnings per share growth this year Advanced Biomed Inc.|GNPX (Genprex Inc) - Earnings growth in current year|Calidi Biotherapeutics (CLDI) - Expected net earnings per share growth this year|Earnings growth in current year SBFM|Earnings per share growth in current year XBIO (Xenetic Biosciences, Inc.)|Earnings growth in current year SLRX (salariuspharma.com)|PPBT - Net earnings per share growth this year|AONC - Earnings per share growth in current year|Earnings per share increase in current year BGNE (BeOne Medicines)|CKPT: Earnings growth in current year|Elevation Oncology Inc. (ELEV) - Earnings growth in current year|ICAD (iCAD) - Earnings growth in current year|Earnings growth in current year ikenaoncology.com|Earnings growth in current year NTBL|Earnings growth in current year Viracta Therapeutics Inc. (VIRX)|Earnings per share growth in current year MorphoSys Inc MOR|Net earnings per share change in current year Ascentage Pharma
